Pnc Financial Services Group, Inc. Ligand Pharmaceuticals Inc Call Options Transaction History
Pnc Financial Services Group, Inc.
- $156 Billion
- Q3 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding LGND
# of Institutions
258Shares Held
18.1MCall Options Held
26.8KPut Options Held
9.3K-
Black Rock Inc. New York, NY2.87MShares$337 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.97MShares$231 Million0.0% of portfolio
-
Janus Henderson Group PLC London, X01.01MShares$118 Million0.05% of portfolio
-
Macquarie Group LTD Australia, C3887KShares$104 Million0.1% of portfolio
-
State Street Corp Boston, MA707KShares$83 Million0.0% of portfolio
About LIGAND PHARMACEUTICALS INC
- Ticker LGND
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 16,882,800
- Market Cap $1.98B
- Description
- Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. Its commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Veklury for the treatment of moderate or severe COVID-19;...